UniProt ID | CCD58_HUMAN | |
---|---|---|
UniProt AC | Q4VC31 | |
Protein Name | Coiled-coil domain-containing protein 58 | |
Gene Name | CCDC58 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 144 | |
Subcellular Localization | ||
Protein Description | ||
Protein Sequence | MAAPSGGVNCEEFAEFQELLKVMRTIDDRIVHELNTTVPTASFAGKIDASQTCKQLYESLMAAHASRDRVIKNCIAQTSAVVKNLREEREKNLDDLTLLKQLRKEQTKLKWMQSELNVEEVVNDRSWKVFNERCRIHFKPPKNE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
46 | Acetylation | PTASFAGKIDASQTC CCHHHCCCCCHHHHH | 33.70 | 25953088 | |
54 | Acetylation | IDASQTCKQLYESLM CCHHHHHHHHHHHHH | 46.88 | 25953088 | |
72 | Acetylation | ASRDRVIKNCIAQTS HCHHHHHHHHHHHHH | 42.80 | 26051181 | |
74 | Glutathionylation | RDRVIKNCIAQTSAV HHHHHHHHHHHHHHH | 2.01 | 22555962 | |
128 | Acetylation | VVNDRSWKVFNERCR HHCCCCHHHHHHCCC | 37.89 | 26051181 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CCD58_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CCD58_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CCD58_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PCBP2_HUMAN | PCBP2 | physical | 26344197 | |
PIPNA_HUMAN | PITPNA | physical | 26344197 | |
STABP_HUMAN | STAMBP | physical | 26344197 | |
CCD58_HUMAN | CCDC58 | physical | 27499296 | |
TIM14_HUMAN | DNAJC19 | physical | 27499296 | |
AFG32_HUMAN | AFG3L2 | physical | 27499296 | |
FMT_HUMAN | MTFMT | physical | 27499296 | |
TIM16_HUMAN | PAM16 | physical | 27499296 | |
CYC_HUMAN | CYCS | physical | 27499296 | |
ECH1_HUMAN | ECH1 | physical | 27499296 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-83 AND LYS-100, AND MASSSPECTROMETRY. |